NOT-DK-23-001: Notice RFA-DK-22-010 "Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)" Is Being Reissued

Notice RFA-DK-22-010 "Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)" Is Being Reissued

Notice Number:

NOT-DK-23-001

Key Dates

Release Date:

November 18, 2022

Related Announcements

RFA-DK-22-010: Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)

RFA-DK-23-002: RFA-DK-23-002:Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice informs potential applicants that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has reissued RFA-DK-22-010, “Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)” to add review criteria that were missing in Section V. Application Review Information.

The review criteria have been corrected in the reissued Funding Opportunity Announcement RFA-DK-23-002: Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed).

Inquiries

Please direct all inquiries to:

Paul A. Rushing, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8895
Email: [email protected]